Johnson & Johnson (JNJ) Tops Q1 EPS by 19c; adjusts forecast
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $231.29 +1.27%
Revenue Growth %: +5.1%
Financial Fact:
Cost of products sold: 5.49B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +5.1%
Financial Fact:
Cost of products sold: 5.49B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
(Updated - April 15, 2025 6:41 AM EDT)
Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.77, $0.19 better than the analyst estimate of $2.58. Revenue for the quarter came in at $21.89 billion versus the consensus estimate of $21.57 billion.
GUIDANCE:
Johnson & Johnson sees FY2025 EPS of $10.50-$10.70, versus the consensus of $10.50. JNJ sees FY2025 operational sales guidance at $92 billion at the midpoint, versus the consensus of $90.3 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- A. O. Smith CEO Stephen Shafer named chairman
- Lockheed Martin wins $83 million Army missile contract
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
